Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection
Tóm tắt
Từ khóa
Tài liệu tham khảo
Acosta, 1994, Histopathologic and humoral study of Balb/c mice inoculated with BCG by different routes, Arch. Med. Res., 25, 159
Andersen, 2005, TB subunit vaccines – putting the pieces together, Microbes Infect., 7, 911, 10.1016/j.micinf.2005.03.013
Arriaga, 2002, Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis, Clin. Exp. Immunol., 128, 229, 10.1046/j.1365-2249.2002.01832.x
Bretscher, 2002, What information is needed to design effective vaccination against intracellular pathogens causing chronic disease?, Expert Rev. Vaccines, 1, 179, 10.1586/14760584.1.2.179
Casadevall, 2003, Antibody-mediated regulation of cellular immunity and the inflammatory response, Trends Immunol., 24, 474, 10.1016/S1471-4906(03)00228-X
Coates, 1981, Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies, Lancet, 2, 167, 10.1016/S0140-6736(81)90355-X
Daffe, 1999, The capsule of Mycobacterium tuberculosis and its implications for pathogenicity, Tuber. Lung Dis., 79, 153, 10.1054/tuld.1998.0200
Devi, 2002, Purification and characterization of three immunodominant proteins (38, 30, and 16kDa) of Mycobacterium tuberculosis, Protein Expression Purif., 24, 188, 10.1006/prep.2001.1569
Dietrich, 2003, Novel vaccination strategies based on recombinant Mycobacterium bovis BCG, Int. J. Med. Microbiol., 292, 441, 10.1078/1438-4221-00227
Falero-Diaz, 2000, Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery, Int. Arch. Allergy Immunol., 122, 143, 10.1159/000024370
Girard, 2005, A review of vaccine research and development: tuberculosis, Vaccine, 23, 5725, 10.1016/j.vaccine.2005.07.045
Glatman-Freedman, 2003, Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy, FEMS Immunol. Med. Microbiol., 39, 9, 10.1016/S0928-8244(03)00172-X
Glatman-Freedman, 1998, Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis, Clin. Microbiol. Rev., 11, 514, 10.1128/CMR.11.3.514
Igietseme, 2004, Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens, Expert Rev. Vaccines, 3, 23, 10.1586/14760584.3.1.23
Ivanyi, 1994, Specificity and function of T and B cell recognition in tuberculosis, 437
Ivanyi, 1985, Studies with monoclonal antibodies to mycobacteria, 59
Jain, 2008, Extensively drug-resistant tuberculosis: current challenges and threats, FEMS Immunol. Med. Microbiol., 53, 145, 10.1111/j.1574-695X.2008.00400.x
Lee, 1992, Characterization of the major membrane protein of virulent Mycobacterium tuberculosis, Infect. Immun., 60, 2066, 10.1128/IAI.60.5.2066-2074.1992
Ly, 2008, Tuberculosis: vaccines in the pipeline, Expert Rev. Vaccines, 7, 635, 10.1586/14760584.7.5.635
Olivares, 2006, The effect of the administration of human gamma globulins in a model of BCG infection in mice, Tuberculosis (Edinburgh), 86, 268, 10.1016/j.tube.2006.01.006
Reece, 2008, Rational design of vaccines against tuberculosis directed by basic immunology, Int. J. Med. Microbiol., 298, 143, 10.1016/j.ijmm.2007.07.004
Regnault, 1999, Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization, J. Exp. Med., 189, 371, 10.1084/jem.189.2.371
Reynolds, 1987, Identification and role of immunoglobulins in respiratory secretions, Eur. J. Respir. Dis., 9, 103
Snewin, 1999, Assessment of immunity to mycobacterial infection with luciferase reporter constructs, Infect. Immun., 67, 4586, 10.1128/IAI.67.9.4586-4593.1999